![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious... Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. Show more
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the completion of its purchase of...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief...
Integration of AL102 and IM-1021 completed Topline data for Phase 3 RINGSIDE trial of AL102 expected in second half of 2025 IM-1021 and IM-3050 IND submissions expected in first quarter of 2025...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, PhD, President and...
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Kinney Horn as Chief...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.34 | -2.22804718218 | 15.26 | 16.76 | 14.715 | 717765 | 15.6927626 | CS |
4 | 0.96 | 6.87679083095 | 13.96 | 16.76 | 13.515 | 824574 | 14.7950047 | CS |
12 | -9.61 | -39.1765185487 | 24.53 | 26.7 | 13.515 | 802810 | 16.48871369 | CS |
26 | 7.38 | 97.8779840849 | 7.54 | 30.958 | 7.4834 | 720747 | 18.39966065 | CS |
52 | 9.2 | 160.839160839 | 5.72 | 30.958 | 5.26 | 448208 | 16.24891123 | CS |
156 | -1.99 | -11.7681845062 | 16.91 | 30.958 | 2.09 | 223884 | 15.48901374 | CS |
260 | -0.74 | -4.72541507024 | 15.66 | 63.78 | 2.09 | 209767 | 17.33985244 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions